Welcome to the WGND Blog

4 Feb 2010
by Working Group

Welcome, and happy Monday! The Working Group for New Drugs of the Stop TB Partnership has some good news to share – starting today, we have launched a new blog.

As you well know, there are armies of people hard at work to make a difference in the war on TB, and lots of encouraging developments in the effort to develop new drug regimens. Our Working Group believes that it is important for us to share our successes and learnings with each other in a digital fashion. The WGND blog provides a quick way to comment on news, and alert each other to emerging theories and studies. It also helps us foster a strong and enduring community among those of us who are working together in the partnership – and others who care about the continuing fight to shorten TB therapy, treat resistant forms, and speed our progress.

So what does this mean for you? We ask that you:

  1. Please subscribe to the blog by setting up an RSS feed or clicking to subscribe by email. (both options are available in the sidebar)
  2. Pass the word along to those people who you think will be interested in reading it.
  3. Consider writing a post or two if you have information you would like to share. To contact the editor and suggest a topic, just
  4. And, if one of our blog posts stirs you up, please comment! We want to hear your point of view, and want to hear about additional resources you’d like to provide to the community.

The blog will cover very serious developments, as well as some fun ones – in a few weeks, for example, we will be posting photos from the Jacques Grossett Symposium.

Thanks for reading this far. Let us know what you think, either on the blog itself or via email.


Mel Spigelman, Co-chair, the Working Group for New Drugs

Bill Bishai, Co-chair, the Working Group for New Drugs

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...